Diabetes therapy : research, treatment and education of diabetes and related disorders

Tirzepatide’s early effects on blood sugar and weight in people with type 2 diabetes in Japan: Study plan and starting data

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Abstract

Tirzepatide has shown good efficacy and safety in managing type 2 diabetes.

  • Tirzepatide may improve glycemic control in early stage type 2 diabetes.
  • The study focused on the real-world effectiveness of tirzepatide in Japan.
  • Early intensive intervention in type 2 diabetes is recognized as important.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Jun '25
Comparing effectiveness and safety of tirzepatide (10 and 15 mg) and semaglutide (2.4 mg) for treating obesity and overweight in type 2 diabetes patients
top 5% journal
cited by 10 papers
randomized controlled trial
Oct '25
Tirzepatide versus Semaglutide effects on blood sugar and weight in people with type 2 diabetes
top 20% journal
cited by 7 papers
journal article
Aug '21
Weekly tirzepatide compared to daily insulin as add-on treatments for type 2 diabetes with metformin, with or without SGLT2 inhibitors
top 1% journal
cited by 536 papers
randomized controlled trial
May '23
Study setup and participant details for adults with type 2 diabetes in the weekly injectable semaglutide trial
top 10% journal
cited by 17 papers
research support, non-u.s. gov't
Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 30 papers
systematic review
Mar '25
Daily Oral Semaglutide Use in Adults with Type 2 Diabetes in Real-Life Italy
top 20% journal
cited by 6 papers
journal article
Sep '24
Daily Oral Semaglutide Use in Adults with Type 2 Diabetes: A Real-World Study Across Multiple UK Centers
top 20% journal
cited by 12 papers
clinical trial, phase iv

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #54
GLP-1 drugs don't build habits — and that gap is costing patients their results
5 days ago7 studies
issue #53
Semaglutide slowed aging and extended lifespan in older female mice
1 week ago7 studies
issue #52
GLP-1 drugs linked to lower Parkinson's risk in people with type 2 diabetes
2 weeks ago7 studies
issue #51
Semaglutide linked to nearly double the risk of a rare eye condition in people with diabetes
3 weeks ago7 studies
issue #50
A once-daily pill beat placebo on weight loss — and it wasn't semaglutide
4 weeks ago7 studies
issue #49
GLP-1 drugs work even without weight loss — and scientists are finally mapping why
5 weeks ago7 studies
issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
6 weeks ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
7 weeks ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
8 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief